1246819-46-4

1246819-46-4 structure

Name: Eperisone-d10 hydrochloride
Chemical Name: Eperisone-d10 hydrochloride
CAS Number: 1246819-46-4
Molecular Formula: C₁₇H₁₆D₁₀ClNO
Molecular Weight: 305.91
Catalog: Research Areas Neurological Disease
Create Date: 2021-11-07 08:09:16
Modify Date: 2024-01-14 09:33:34
Eperisone-d10 ((±)-Eperisone-d10) hydrochloride is the deuterium labeled Eperisone hydrochloride. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is an antispastic agent used for treatment of diseases characterized by muscle stiffness and pain. It works by relaxing both skeletal muscles and vascularsmooth muscles, thus demonstrating avariety of effects such as reduction ofmyotonia, improvement of circulationand suppression of the pain reflex. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is a centrally acting muscle relaxant inhibiting the pain reflex pathway, having a vasodilator effect[1][2 [3].

Name	Eperisone-d10 hydrochloride

Description	Eperisone-d10 ((±)-Eperisone-d10) hydrochloride is the deuterium labeled Eperisone hydrochloride. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is an antispastic agent used for treatment of diseases characterized by muscle stiffness and pain. It works by relaxing both skeletal muscles and vascularsmooth muscles, thus demonstrating avariety of effects such as reduction ofmyotonia, improvement of circulationand suppression of the pain reflex. Eperisone Hydrochloride ((±)-Eperisone hydrochloride) is a centrally acting muscle relaxant inhibiting the pain reflex pathway, having a vasodilator effect[1][2 [3].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Cabitza P, et al. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. Eur Rev Med Pharmacol Sci. 2008 Jul-Aug;12(4):229-35. [3]. Frandisco Colomer Rusinvol, et al. Effects of Two Diffferent Doses of Eperisone in the Treatment of Acute Low Back Pain. The Journal of Applied Research. [4]. Bavage S, et al. Clinical efficacy and safety of eperisone for low back pain: A systematic literature review. Pharmacol Rep. 2016 Oct;68(5):903-12.

Molecular Formula	C₁₇H₁₆D₁₀ClNO
Molecular Weight	305.91

1246819-46-4	259796-99-1
56839-43-1	718612-62-5
1189959-13-4	120092-65-1
1215821-44-5	1216539-56-8
1185160-65-9	1346603-63-1
1707562-99-9	1178332-59-6
1184671-54-2	1183408-11-8
1179143-48-6	1184472-03-4
1179139-16-2	1483755-24-3
1347697-79-3	167951-55-5